P53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent
Details for Australian Patent Application No. 2005215910 (hide)
International Classifications
Event Publications
31 August 2006 PCT application entered the National Phase
PCT publication WO2005/080593 Priority application(s): WO2005/080593
1 May 2008 Application Accepted
Published as AU-B-2005215910
28 August 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005215913-Dual or multi-chamber tube
2005215906-Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser